Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.

Dubcenco E, Ottaway CA, Chen DL, Baker JP.

Eur J Gastroenterol Hepatol. 2006 May;18(5):565-6.

PMID:
16607158
2.

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.

Thomas CW Jr, Weinshenker BG, Sandborn WJ.

Inflamm Bowel Dis. 2004 Jan;10(1):28-31.

PMID:
15058523
3.

Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.

Vadikolias K, Kouklakis G, Heliopoulos I, Argyropoulou P, Papanas N, Tzilonidou M, Prassopoulos P, Piperidou H.

Eur J Gastroenterol Hepatol. 2007 Feb;19(2):159-62.

PMID:
17273002
4.

[Anti-TNF (infliximab) treatment in Crohn disease: safety profile].

Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalù AB.

Recenti Prog Med. 2006 Feb;97(2):108-12; quiz 122. Review. Italian.

PMID:
16671277
5.

Genital condylomata in a patient receiving infliximab for Crohn's disease.

Somasekar A, Alcolado R.

Postgrad Med J. 2004 Jun;80(944):358-9.

6.

Psoriasiform and pustular eruption induced by infliximab.

Takahashi H, Hashimoto Y, Ishida-Yamamoto A, Ashida T, Kohgo Y, Iizuka H.

J Dermatol. 2007 Jul;34(7):468-72.

PMID:
17584325
7.

Anti-TNF therapy for Crohn's disease: a perspective (infliximab is not the drug we have been waiting for)

Shanahan F.

Inflamm Bowel Dis. 2000 May;6(2):137-9. No abstract available.

PMID:
10833074
8.

Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.

de Rossi TM, Krauss N, Voll RE, Nägel A, Weidenhiller M, Konturek PC, Hahn EG, Raithel M.

Digestion. 2008;78(4):195-200. doi: 10.1159/000187637. Epub 2008 Dec 22.

PMID:
19122456
9.

Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.

Izbéki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Molnár T.

Inflamm Bowel Dis. 2008 Mar;14(3):429-31. No abstract available.

PMID:
17973302
10.

Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease.

Ritz MA, Jost R.

Inflamm Bowel Dis. 2001 Nov;7(4):327. No abstract available.

PMID:
11720324
11.

[Indications and results of infliximab in Crohn's disease].

Karoui S, Boubaker J, Filali A.

Tunis Med. 2004 Dec;82(12):1057-63. Review. French.

PMID:
15822505
12.

Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.

Martínez F, Nos P, Benlloch S, Ponce J.

Inflamm Bowel Dis. 2001 Nov;7(4):323-6.

PMID:
11720323
13.

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study.

Vermeire S, Noman M, Van Assche G, Baert F, Van Steen K, Esters N, Joossens S, Bossuyt X, Rutgeerts P.

Gastroenterology. 2003 Jul;125(1):32-9.

PMID:
12851868
14.

[A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].

Guyot A, Begon E, Abramowitz L, Landry J, Marinho E, Descamps V, Crickx B.

Ann Dermatol Venereol. 2009 Nov;136(11):806-10. doi: 10.1016/j.annder.2009.09.009. Epub 2009 Oct 23. French.

PMID:
19917434
15.
16.

Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.

Panagi S, Palka W, Korelitz BI, Taskin M, Lessnau KD.

Inflamm Bowel Dis. 2004 May;10(3):274-7.

PMID:
15290924
17.
18.

Crohn's disease, infliximab and idiopathic thrombocytopenic purpura.

Selby LA, Hess D, Shashidar H, de Villiers WJ, Selby LA.

Inflamm Bowel Dis. 2004 Sep;10(5):698-700. No abstract available.

PMID:
15472539
19.

Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study.

Ryan BM, Russel MG, Schurgers L, Wichers M, Sijbrandij J, Stockbrugger RW, Schoon E.

Aliment Pharmacol Ther. 2004 Oct 15;20(8):851-7.

20.

Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.

del Valle García-Sánchez M, Gómez-Camacho F, Poyato-González A, Iglesias-Flores EM, de Dios-Vega JF, Sancho-Zapatero R.

Inflamm Bowel Dis. 2004 Sep;10(5):701-2. No abstract available.

PMID:
15472541

Supplemental Content

Support Center